Gene Query: L3MBTL2

Dataset Description Geneva Score
4sU-seq of HFF exposed to salt and heat stress 18.93
RNAseq Study in CC-671 Treated Cal-51 Cells 13.12
Comparison of microRNA Profiling Platforms (HTS) 12.82
Comparison of microRNA Profiling Platforms 12.82
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 12.18
CD95/Fas ligand mRNA is toxic to cells 11.73
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 11.3
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 11.3
RNA-seq of IL-4 stimulated human keratinocytes 11.18
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 11.01
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 10.98
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 10.93
Endothelial gene expression analysis 10.93
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 10.9
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 10.79
Human HAP1 cells before and after nutrient deprivation 10.7
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 10.7
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 10.26
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 10.26
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 9.8
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 9.44
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 9.35
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 9.22
Silencing p300 in MCF7 cells to study expression and alternative splicing 9.11
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 8.89
RNAseq Analysis in glioblastoma cells treated with Mepazine 8.71
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 8.57
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 8.36
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 8.12
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 8.12
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 8.0
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 8.0
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 7.96
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 7.95
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 7.85
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 7.85
KLF6-dependent transcription in renal cancer cells 7.81
RNA-seq of YB5 cells treated with Proscillaridin A 7.72
AUF-1 affected genes in human skin cells 7.62
Stem and effector CD8 T-cells from human cancers 7.54
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 7.53
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 7.52
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 7.48
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 7.48
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 7.45
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 7.34
Genome wide miR-191 target profile determined by RIP and gene expression profiling 7.12
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 7.12
MeRIP-seq for heat shock in B-cell lymphoma cells 7.11
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 7.09
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 7.06
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 7.03
LNCaP treated with iBET 7.01
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 6.93
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 6.76
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 6.68
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 6.52
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 6.47
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 6.45
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 6.45
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 6.44
Co-transcriptional loading of RNA export factors shapes the human transcriptome 6.39
RNAseq of HEK293 cells after Chtop knockdown 6.39
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 6.38
RNA transcriptome analysis during HSV-1 infection 6.37
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 6.33
A Unique Epigenomic Landscape Defines Human Erythropoiesis 6.33
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 6.29
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 6.24
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 6.23
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 6.21
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 6.13
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 6.09
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 6.08
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 6.06
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 6.06
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 6.01
snRNAs as regulators of alternative splicing 5.96
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 5.96
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 5.93
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 5.93
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 5.92
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 5.92
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 5.92
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 5.91
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 5.83
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 5.79
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 5.75
RNA-seq analysis of differentiating human erythroblasts 5.69
Total RNA-seq in ALL-SIL upon JQ1 inhibition 5.67
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 5.58
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 5.58
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 5.57
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 5.55
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 5.52
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 5.48
Rorc disruption in human FG pancreatic cancer cells 5.48
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 5.39
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 5.38
The evolution of N6-methyladenosine in primates 5.38
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 5.29
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 5.24
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 5.13
Global analysis of alternative splicing regulated by RBM10 5.08
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 5.08
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 5.05
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 5.05
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 5.03
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 5.02
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 5.02
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 4.99
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 4.98
Landscape and variation of RNA secondary structure across the human transcriptome 4.93
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 4.92
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 4.91
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 4.91
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 4.91
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 4.84
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 4.84
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 4.83
ETV7 and interferon response 4.83
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 4.81
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 4.7
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 4.68
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 4.61
MYC dependent mRNA translation shapes gene expression and cell biology 4.61
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 4.57
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 4.52
RNA-seq in transgenic cells 4.51
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 4.5
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 4.49
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 4.49
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 4.49
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 4.48
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 4.47
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 4.47
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 4.46
HEK293 TFAM Knockout Expression Study 4.46
RNA-seq analysis of BAP1-depleted uveal melanoma cells 4.45
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 4.43
LncRNA-GAS5 negative regulation of YAP-target genes expression 4.42
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 4.42
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 4.42
Effect of CHKA knockdown on C4-2 cell transcriptome 4.41
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 4.39
Effect of PRDM11 depletion in U2932 cells 4.38
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 4.36
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 4.34
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 4.32
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 4.32
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 4.28
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 4.26
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 4.25
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 4.25
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 4.22
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 4.22
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 4.2
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 4.17
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 4.13
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 4.12
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 4.11
BAF controls genome accessibility 4.11
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 4.09
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 4.09
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 4.06
Tracking of dCas9-methyltransferase footprints 4.05
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 3.99
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 3.98
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 3.98
IDH3a KO RNA-seq 3.97
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 3.97
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 3.97
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 3.97
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 3.94
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 3.89
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 3.88
RNA sequencing of BT142 and TS603 cell lines 3.86
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 3.86
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 3.85
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 3.85
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 3.85
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 3.85
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 3.83
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 3.83
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 3.81
Developmental stage specific chromosome architecture in human erythroid cells 3.81
MOF acetyl transferase regulates transcription and respiration in mitochondria 3.8
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 3.8
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 3.79
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 3.78
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 3.76
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 3.76
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 3.75
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 3.75
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 3.75
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 3.73
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 3.73
Identification of HOXB13 target genes responsive to BET inhibitors 3.72
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 3.72
U1 snRNP telescripting regulates size-function stratified human genome 3.71
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 3.71
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 3.7
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 3.69
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 3.69
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 3.67
Gene expression in GBM with Cav3.2 inhibition 3.67
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 3.66
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 3.65
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 3.65
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 3.64
TFAP2C signalling in human fibroblasts 3.63
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 3.63
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 3.62
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 3.62
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.61
Biological effect of chronic mistranslation in mammalian cells 3.61
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 3.6
JunB control of keratinocyte-mediated inflammation [RNA-seq] 3.6
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.6
Modulation of nonsense-mediated decay by rapamycin 3.56
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 3.54
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 3.54
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 3.51
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 3.49
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 3.48
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 3.47
Identification of Sin3B regulated genes during quiescence 3.45
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 3.4
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 3.39
Survival of pancreatic cancer cells lacking KRAS function 3.39
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 3.36
Effect of FGF13 depletion on the H460 cell line 3.36
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 3.36
Gene expression changes after LOC550643 silencing 3.35
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 3.35
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 3.31
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 3.3
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 3.28
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 3.28
PRDM1 inhibits proliferation of human colon cancer organoids 3.28
R430: A potent inbibitor of DNA and RNA viruses 3.25
EWSR1 influences alternative splicing through direct and indirect mechanisms 3.18
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 3.18
Transcriptional responses of melanoma cells to BRAF inhibition 3.16
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  3.15
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 3.14
Identification of long noncoding RNAs regulated by p53 3.13
Paxillin regulates genomic networks in prostate cancer [C4-2] 3.08
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 3.02
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.96
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 2.94
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 2.94
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 2.94
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 2.91
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 2.9
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 2.86
METTL3 and WTAP 2.85
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 2.84
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 2.84
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 2.84
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 2.79
Seletive inhibition of CDK9 in DLBCL cell lines 2.79
SNHG5 siRNA knock down in HCT116 cells 2.72
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 2.69
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 2.68
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 2.66
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 2.65
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 2.65
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 2.65
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 2.62
Cajal bodies are linked to genome conformation 2.6
Cajal bodies are linked to genome conformation [RNA-Seq] 2.6
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 2.6
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 2.6
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 2.54
Searching for target genes of miR-508/509/506/514 in HCT116 cells 2.52
A20 regulates canonical wnt-signaling through an interaction with RIPK4 2.51
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 2.49
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 2.48
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 2.47
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 2.47
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 2.46
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 2.44
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 2.41
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 2.39
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 2.39
LIN28A modulates splicing and gene expression programs in breast cancer cells 2.38
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 2.38
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 2.38
Functional significance of the HIV-1 Tat signature amino acid residues 2.37
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 2.36
RNA-Seq from human ILC transitional populations 2.35
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 2.35
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 2.34
ADAR1-editing of cellular and measles virus-derived duplex RNA 2.33
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 2.33
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 2.32
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 2.31
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 2.3
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 2.26
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 2.25
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 2.23
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 2.17
Polarized B -cell functions 2.15
BACH2 in human plasma cell fate decision 2.11
Controlling for gene expression changes in transcription factor protein networks. 2.1
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 2.1
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 2.1
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 2.1
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.08
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 2.08
Capturing the Interactome of Newly Transcribed RNA (RICK) 2.03
Capturing the Interactome of Newly Transcribed RNA 2.03
Discovering human diabetes-risk gene function with genetics and physiological assays 2.02
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 2.02
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 2.01
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 1.99
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 1.98
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.95
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 1.92
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 1.92
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 1.92
HNRNPM-regulated splicing dependencies in prostate cancer 1.89
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 1.89
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.88
Gene expression analysis in response to hypoxic pathway inhibition 1.88
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.87
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.84
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 1.79
FBXW7 modulates stress response by post-translational modification of HSF1 1.79
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 1.78
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 1.77
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 1.77
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 1.77
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.71
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 1.71
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 1.71
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.71
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.69
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 1.67
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.67
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 1.66
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.65
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.64
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 1.64
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 1.64
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 1.64
The Genetic Landscape of Diamond-Blackfan Anemia 1.62
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 1.61
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.59
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.59
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.59
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.56
Targeted enhancer activation by a subunit of the integrator complex 1.53
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 1.51
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 1.5
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 1.5
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 1.5
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.49
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 1.49
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 1.48
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 1.48
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 1.48
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 1.47
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.47
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 1.47
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 1.45
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 1.45
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 1.45
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.44
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 1.41
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 1.41
ARS2 is a general suppressor of pervasive transcription [RNAseq] 1.39
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.38
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.35
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.34
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.34
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.34
CD73 knockdown effect in pancreatic cancer cell lines 1.33
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 1.32
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 1.27
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 1.24
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.23
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.23
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 1.2
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 1.19
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 1.18
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 1.16
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.16
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.16
RNAseq of T-ALL upon long non coding rna purturbation 1.15
Disruption of GRIN2B impairs differentiation in human neurons 1.14
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 1.14
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 1.13
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 1.07
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.07
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.07
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.07
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.04
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.04
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 1.03
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 1.0
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.98
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.98
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.98
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.98
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.98
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 0.97
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.97
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.95
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 0.95
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 0.94
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 0.94
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.9
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.9
Determining mRNA half-lives on a transcriptome-wide scale 0.89
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 0.87
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.87
Transposon-based construction of strand-specific RNA-seq libraries 0.86
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 0.83
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 0.83
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.83
Human cells contain natural double-stranded RNAs with potential regulatory capacity 0.81
Identification of a LIF-responsive replication-competent human β cell 0.81
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.78
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.74
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.74
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.73
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.73
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 0.68
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 0.65
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 0.65
hNSCs siRNA NOVA2 0.65
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.64
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.62
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 0.61
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 0.61
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.59
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.58
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.55
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 0.55
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 0.54
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 0.54
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 0.53
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.49
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.48
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.48
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.44
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.43
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.43
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.42
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.4
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.36
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.33
p53 activity results in DNA replication fork processivity 0.33
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.31
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.3
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.3
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.3
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 0.3
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.3
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.27
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 0.25
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 0.25
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.24
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.22
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.22
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.22
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.21
Co-regulation of splicing by Rbfox1 and hnRNP M 0.21
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 0.21
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.21
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.17
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.17
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.15
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.14
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.14
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.13
Redifferentiation of expanded human islet β cells by inhibition of ARX 0.13
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 0.13
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.12
miRNAs affected by antagomiR-17 treatment 0.1
The role of m6A/m-RNA methylation in stress response regulation 0.09
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.09
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.08
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.08
N6-methyladenine DNA Modification in Glioblastoma 0.08
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 0.08
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.08
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.08
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.06
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.06
Function and hormonal regulation of GATA3 in human first trimester placentation 0.06
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.06
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.06
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.06
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 0.05
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 0.05
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.02
Identification of global XBP1s target gene expression in human prostate cancer cells 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation